Laurence H M Pierrache1, Adva Kimchi2, Rinki Ratnapriya3, Lisa Roberts4, Galuh D N Astuti5, Alexey Obolensky2, Avigail Beryozkin2, Martha J H Tjon-Fo-Sang6, Jose Schuil7, Caroline C W Klaver8, Ernie M H F Bongers9, Lonneke Haer-Wigman9, Nicoline Schalij10, Martijn H Breuning11, Gratia M Fischer12, Eyal Banin2, Raj S Ramesar4, Anand Swaroop3, L Ingeborgh van den Born13, Dror Sharon2, Frans P M Cremers14. 1. The Rotterdam Eye Hospital, Rotterdam, The Netherlands; Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. 2. Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 3. Neurobiology-Neurodegeneration & Repair Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland. 4. UCT/MRC Human Genetics Research Unit, Division of Human Genetics, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. 5. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands; Division of Human Genetics, Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia. 6. The Rotterdam Eye Hospital, Rotterdam, The Netherlands. 7. Bartiméus Institute for the Visually Impaired, Zeist, The Netherlands. 8. Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands. 9. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 10. Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. 11. Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. 12. Department of Ophthalmology, Dr. George Mukhari Academic Hospital, Sefako Makgatho Health Sciences University (SMU), Ga-Rankuwa, Pretoria, South Africa. 13. The Rotterdam Eye Hospital, Rotterdam, The Netherlands; Rotterdam Ophthalmic Institute, Rotterdam, The Netherlands. 14. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands; Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands. Electronic address: Frans.Cremers@radboudumc.nl.
Abstract
PURPOSE: To identify the genetic cause of and describe the phenotype in 4 families with autosomal recessive retinitis pigmentosa (arRP) that can be associated with pseudocoloboma. DESIGN: Case series. PARTICIPANTS: Seven patients from 4 unrelated families with arRP, among whom 3 patients had bilateral early-onset macular pseudocoloboma. METHODS: We performed homozygosity mapping and whole-exome sequencing in 5 probands and 2 unaffected family members from 4 unrelated families. Subsequently, Sanger sequencing and segregation analysis were performed in additional family members. We reviewed the medical history of individuals carrying IDH3A variants and performed additional ophthalmic examinations, including full-field electroretinography, fundus photography, fundus autofluorescence imaging, and optical coherence tomography. MAIN OUTCOME MEASURES: IDH3A variants, age at diagnosis, visual acuity, fundus appearance, visual field, and full-field electroretinography, fundus autofluorescence, and optical coherence tomography findings. RESULTS: We identified 7 different variants in IDH3A in 4 unrelated families, that is, 5 missense, 1 nonsense, and 1 frameshift variant. All participants showed symptoms early in life, ranging from night blindness to decreased visual acuity, and were diagnosed between the ages of 1 and 11 years. Four participants with biallelic IDH3A variants displayed a typical arRP phenotype and 3 participants were diagnosed with arRP and pseudocoloboma of the macula. CONCLUSIONS: IDH3A variants were identified as a novel cause of typical arRP in some individuals associated with macular pseudocoloboma. We observed both phenotypes in 2 siblings carrying the same compound heterozygous variants, which could be explained by variable disease expression and warrants caution when making assertions about genotype-phenotype correlations.
PURPOSE: To identify the genetic cause of and describe the phenotype in 4 families with autosomal recessive retinitis pigmentosa (arRP) that can be associated with pseudocoloboma. DESIGN: Case series. PARTICIPANTS: Seven patients from 4 unrelated families with arRP, among whom 3 patients had bilateral early-onset macular pseudocoloboma. METHODS: We performed homozygosity mapping and whole-exome sequencing in 5 probands and 2 unaffected family members from 4 unrelated families. Subsequently, Sanger sequencing and segregation analysis were performed in additional family members. We reviewed the medical history of individuals carrying IDH3A variants and performed additional ophthalmic examinations, including full-field electroretinography, fundus photography, fundus autofluorescence imaging, and optical coherence tomography. MAIN OUTCOME MEASURES: IDH3A variants, age at diagnosis, visual acuity, fundus appearance, visual field, and full-field electroretinography, fundus autofluorescence, and optical coherence tomography findings. RESULTS: We identified 7 different variants in IDH3A in 4 unrelated families, that is, 5 missense, 1 nonsense, and 1 frameshift variant. All participants showed symptoms early in life, ranging from night blindness to decreased visual acuity, and were diagnosed between the ages of 1 and 11 years. Four participants with biallelic IDH3A variants displayed a typical arRP phenotype and 3 participants were diagnosed with arRP and pseudocoloboma of the macula. CONCLUSIONS:IDH3A variants were identified as a novel cause of typical arRP in some individuals associated with macular pseudocoloboma. We observed both phenotypes in 2 siblings carrying the same compound heterozygous variants, which could be explained by variable disease expression and warrants caution when making assertions about genotype-phenotype correlations.
Authors: Dyonne T Hartong; Mayura Dange; Terri L McGee; Eliot L Berson; Thaddeus P Dryja; Roberta F Colman Journal: Nat Genet Date: 2008-09-21 Impact factor: 38.330
Authors: Daniel F Kiernan; Rohan J Shah; Seenu M Hariprasad; Michael A Grassi; Kent W Small; Joseph P Kiernan; William F Mieler Journal: Ophthalmology Date: 2011-02-18 Impact factor: 12.079
Authors: Susanne Kohl; Ditta Zobor; Wei-Chieh Chiang; Nicole Weisschuh; Jennifer Staller; Irene Gonzalez Menendez; Stanley Chang; Susanne C Beck; Marina Garcia Garrido; Vithiyanjali Sothilingam; Mathias W Seeliger; Franco Stanzial; Francesco Benedicenti; Francesca Inzana; Elise Héon; Ajoy Vincent; Jill Beis; Tim M Strom; Günther Rudolph; Susanne Roosing; Anneke I den Hollander; Frans P M Cremers; Irma Lopez; Huanan Ren; Anthony T Moore; Andrew R Webster; Michel Michaelides; Robert K Koenekoop; Eberhart Zrenner; Randal J Kaufman; Stephen H Tsang; Bernd Wissinger; Jonathan H Lin Journal: Nat Genet Date: 2015-06-01 Impact factor: 38.330
Authors: Muhammad Ajmal; Muhammad Imran Khan; Kornelia Neveling; Yar Muhammad Khan; Maleeha Azam; Nadia Khalida Waheed; Christian P Hamel; Tamar Ben-Yosef; Elfride De Baere; Robert K Koenekoop; Rob W J Collin; Raheel Qamar; Frans P M Cremers Journal: J Med Genet Date: 2014-04-15 Impact factor: 6.318
Authors: Koji M Nishiguchi; Almudena Avila-Fernandez; Ramon A C van Huet; Marta Corton; Raquel Pérez-Carro; Esther Martín-Garrido; María Isabel López-Molina; Fiona Blanco-Kelly; Lies H Hoefsloot; Wendy A van Zelst-Stams; Pedro J García-Ruiz; Javier Del Val; Silvio Alessandro Di Gioia; B Jeroen Klevering; Bart P C van de Warrenburg; Carlos Vazquez; Frans P M Cremers; Blanca García-Sandoval; Carel B Hoyng; Rob W J Collin; Carlo Rivolta; Carmen Ayuso Journal: Ophthalmology Date: 2014-03-31 Impact factor: 12.079
Authors: Nisha Patel; Mohammed A Aldahmesh; Hisham Alkuraya; Shamsa Anazi; Hadeel Alsharif; Arif O Khan; Asma Sunker; Saleh Al-Mohsen; Emad B Abboud; Sawsan R Nowilaty; Mohammed Alowain; Hamad Al-Zaidan; Bandar Al-Saud; Ali Alasmari; Ghada M H Abdel-Salam; Mohamed Abouelhoda; Firdous M Abdulwahab; Niema Ibrahim; Ewa Naim; Banan Al-Younes; Abeer E AlMostafa; Abdulelah AlIssa; Mais Hashem; Olga Buzovetsky; Yong Xiong; Dorota Monies; Nada Altassan; Ranad Shaheen; Selwa A F Al-Hazzaa; Fowzan S Alkuraya Journal: Genet Med Date: 2015-09-10 Impact factor: 8.822
Authors: Serena Tommasini-Ghelfi; Kevin Murnan; Fotini M Kouri; Akanksha S Mahajan; Jasmine L May; Alexander H Stegh Journal: Sci Adv Date: 2019-05-22 Impact factor: 14.957
Authors: Amy S Findlay; Roderick N Carter; Becky Starbuck; Lisa McKie; Klára Nováková; Peter S Budd; Margaret A Keighren; Joseph A Marsh; Sally H Cross; Michelle M Simon; Paul K Potter; Nicholas M Morton; Ian J Jackson Journal: Dis Model Mech Date: 2018-12-18 Impact factor: 5.758
Authors: G Jane Farrar; Matthew Carrigan; Adrian Dockery; Sophia Millington-Ward; Arpad Palfi; Naomi Chadderton; Marian Humphries; Anna Sophia Kiang; Paul F Kenna; Pete Humphries Journal: Hum Mol Genet Date: 2017-08-01 Impact factor: 6.150